Depression Clinical Trial
Official title:
Screening for Depression in cADiovasCular pAtients at a Tertiary Center in Trinidad.
This was an observational study aimed to screen patients with cardiovascular disease for depression in Trinidad and Tobago in a tertiary center and to determine if there is a significant association between patients with symptoms of depression and other comorbidities. Patients (N=1203) were randomly selected from the outpatient cardiology clinics at the Eric Williams Medical Sciences Complex. After fulfilling the inclusion criteria and informed consent were obtained, they were given the case report form which included the Patient Health Questionnaire 9.
The study design was a cross-sectional descriptive study performed from November 2018 to
February 2019. It was performed at the Eric Williams Medical Sciences Complex, Champ Fleurs,
Trinidad. The primary objectives of the study were to screen patients for depression in those
with cardiovascular disease in Trinidad and Tobago and to determine the association between
patients with depression and other comorbidities.
Patients were targeted for participation in the study while waiting to see the attached
physician to the cardiology clinic. Participants were attained at the Eric Williams Medical
Sciences Complex during the days Monday to Friday where there were ongoing cardiology
outpatient clinics. Once informed consent was obtained from these patients, a questionnaire
was administered to these patients in which the primary investigator and/or co-investigator
was/were present on site. The number of participants in this study was 1203 patients. There
were no dropped subjects from the study nor were there any incomplete questionnaires by any
participants. The sample size for this study was calculated to be 1159 patients. Based on a
study done by Huffman, it was estimated that 40% of patients with cardiovascular disease also
have depression(2). The Type I error rate 5% (α = 0.05) making the Type II error rate 95% (β
= 0.95) with a statistical power of 90%. Assuming a 10% patient decline and attrition rate
and a minimum detectable difference of 10%, the estimated sample size was calculated to be
1159 patients.
Data collection was performed by the researchers of the study along with eight specifically
trained and oriented medical students. All data collectors in the study were supervised by
primary investigator and co-investigator of the study so that in the event of any adverse
events such as acute psychosis or any acute cardiology emergencies, patients could have been
referred directly to the accident and emergency department at Eric Williams Medical Sciences
Complex where routine medical care could have been executed.
Additionally, there was an attached consent form which was also approved by the ethical
committee of the University of the West Indies, St. Augustine. This consent form clearly
explained to the participants why the research was being conducted, the average duration of
completing the questionnaire, the benefits and any potential risks associated with
participation in the study along with the assurance that confidentiality will be maintained
throughout the entire study and that the patient can stop or not complete the questionnaire
at any point without any facing repercussions. This information was documented on the consent
form and also explained by the researchers of the study to each potential participant. All
additional questions from patients were answered truthfully regardless of if it would have
affected the patient's decision to participate in the study.
Patients were asked to participate in the study as long as they were registered patients at
Eric Williams Medical Sciences Complex in any of the cardiology outpatient clinics. This was
confirmed by matching patients with their registration numbers on the cardiology outpatient
clinic appointment listings. These lists are made prior to each cardiology clinic that is
scheduled every week on Mondays, Tuesdays, Wednesdays, Thursdays and Fridays. The inclusion
criteria for participation in the study included patients who were 18 years old and over
along with registered patients of the cardiology outpatient clinics at Eric Williams Sciences
Complex.
Of note, no rewards or incentives were offered to encourage participation in the study by
subjects nor were there any penalization for declining participation in the study.
Specifically, patients were not offered any monetary payments to encourage their
participation in the study. Patients were allowed to decide on their own, whether or not they
wanted to participate in the study. Subjects were able to participate based on the fulfilling
inclusion criteria and informed consent attained. Of significance, there was no sponsorship
obtained to conduct this study.
Confidentiality of patients was kept and ensured as no patient names were recorded and all
data recorded was de-identified. Patients were uniquely identified using their clinic
registration numbers of the cardiology outpatient clinic. By using registration numbers to
identify patients, this assisted in preventing duplicate collection and entry of data.
Additionally, the database was only accessible to the primary investigator and the
co-investigator of the study. The data was stored on a device which was password protected
and again this password was only available to the primary investigator and co-investigator of
the study. The database was encrypted to ensure the patient's recorded information was safe.
Of importance, no invasive data was collected from participants in this study. No blood
samples were drawn and no drugs being tested were administered to any patients enrolled in
the study. Additionally, any patients deemed as medical emergencies had the opportunity to be
referred to the accident and emergency department of Eric Williams Medical Sciences Complex
where the routine medical protocol was followed and appropriate referrals were made. Some
examples of these emergencies included acute psychosis, acute coronary syndromes, and acute
heart failure.
The scores of the Patient Health Questionnaire-9 were verbally communicated to the patients
in confidentiality by the primary investigator and or co-investigator of the study along with
the interpretation of the score and what it meant on the depression scale. Patients were
given the opportunity to decide if they wanted these results communicated to the physician
seeing them in the cardiology outpatient clinic and if so; the results were given to their
respective physicians who would have decided on appropriate referrals and routine medical
care. This would include appropriate referrals to psychiatry.
The Social Sciences 24 (SPSS, Chicago, Illinois USA) was the software used for the entry of
data and its analysis. Descriptive analyses were performed which were unadjusted. Statistical
significance was accepted as p < 0.05.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A |